ketorolac and sulindac sulfone

ketorolac has been researched along with sulindac sulfone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bassi, FD; Borroni, AP; Ciana, P; Conti, P; Crescenti, D; Dell'Omo, G; Eberini, I; Garofalo, M; Maggi, A; Parravicini, C; Pinto, A; Pruneri, G; Recordati, C; Rizzi, N; Scanziani, E; Vantaggiato, C	1

Other Studies

1 other study(ies) available for ketorolac and sulindac sulfone

Article	Year
Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs. British journal of cancer, 2019, Volume: 120, Issue:5 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Cell Line, Tumor; Computer Simulation; Cyclin-Dependent Kinase Inhibitor p21; Cyclooxygenase Inhibitors; Humans; Ketorolac; Mice; Models, Molecular; Sirtuin 1; Sulindac; Tumor Suppressor Protein p53	2019

Article

Year

Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs.

British journal of cancer, 2019, Volume: 120, Issue:5

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Cell Line, Tumor; Computer Simulation; Cyclin-Dependent Kinase Inhibitor p21; Cyclooxygenase Inhibitors; Humans; Ketorolac; Mice; Models, Molecular; Sirtuin 1; Sulindac; Tumor Suppressor Protein p53

2019